University of California, Los AngelesUnited States
Yunxiang Yan is a Professor in the Department of Anthropology at the University of California, Los Angeles (UCLA). His work focuses on China and Cultural Anthropology , with specific expertise in Economic Anthropology , Family and Kinship , and Individualization . Education: Ph.D. in Social Anthropology from Harvard University (1993). Yan’s research explores the intersection of social change , moral theory , and family dynamics in modern China. His ethnographic studies in rural villages provide foundational insights into exchange theory and cultural globalization . Recent publications analyze food safety , medical ethics , and moral crises in China, reflecting his interdisciplinary approach combining anthropology, sociology, and philosophy. Articles span themes like intergenerational intimacy , political oppression , and networked social structures . Scientific Awards: Guggenheim Fellowship Levenson Prize-winning Research Yan’s work bridges local Chinese studies with global anthropological discourse. He has held positions at the Chinese University of Hong Kong, Johns Hopkins University, and UCLA since 1996. His career reflects a commitment to documenting the lives of ordinary people, rooted in his early experiences as an expelled villager during Maoist China. Contact: yan@anthro.ucla.edu
Massachusetts Institute of TechnologyUnited States
Abhijit Banerjee is a Professor in the Department of Economics at the Massachusetts Institute of Technology (MIT). His research focuses on development economics, public health policy, and social protection programs, particularly addressing poverty and inequality in low- and middle-income countries. He has conducted large-scale experiments evaluating interventions such as conditional cash transfers, universal basic income, and healthcare policies. Key areas of interest include the design and implementation of anti-poverty programs, behavioral economics, and the long-term health impacts of infectious diseases like COVID-19. His work often integrates experimental methods to assess policy effectiveness, with contributions to global health studies and economic development strategies. Notably, his research on the RECOVERY trial evaluates treatments for hospitalized COVID-19 patients, while other studies explore financial spillover effects of electronic government transfers in Indonesia and savings behavior interventions in Chile. Banerjee has collaborated on projects analyzing post-COVID-19 health outcomes, labor market dynamics in India, and the role of trusted messengers in public health communication during crises. Despite the breadth of his contributions, specific details about his educational background, grants, or lab affiliations are not explicitly provided in the source text.
Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.
Stefanos Zenios is Professor at Stanford Graduate School of Business with dual appointments in Entrepreneurship and Operations, Information & Technology . He directs Stanford GSB’s Center for Entrepreneurial Studies and co-directs the Doerr School of Sustainability ’s Program in Ecopreneurship. His Startup Garage course has launched companies like DoorDash while alumni have raised over $3B in venture capital. He co-authored the foundational Biodesign textbook and previously served as Editor-in-Chief of Operations Research . PhD, MIT Operations Research (1996) MA, University of Cambridge (1996) BA, University of Cambridge (1992) Research Focus Dr. Zenios’ work bridges operations research and innovation management , with significant contributions to: Healthcare operations : Administrative cost reduction, organ allocation optimization, and clinical workflow improvements Entrepreneurship : Venture creation frameworks and experiential education Ecopreneurship : Sustainable business model innovation His Precedents Thinking framework (HBR 2025) has gained global recognition for solving systemic inefficiencies. Current research includes the biennial Search Fund Study with Peter Kelly. Scientific Recognition INFORMS Fellow Multiple Best Paper Awards, INFORMS CAREER Award, National Science Foundation (2000) Dhirubhai Ambani Faculty Fellow (2017–2020) George E. Nicholson Award (1997) He has received extensive media coverage in Fast Company , Time Magazine , and Stanford Business . His research has been featured in over 150 press mentions including JAMA , Harvard Business Review , and Health Affairs .
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Jenna Wiens is an Associate Professor of Computer Science and Engineering at the University of Michigan's College of Engineering. She serves as Associate Director of the Artificial Intelligence Lab and co-Director of AI & Digital Health Innovation. Leading the MLD3 research group, her work focuses on machine learning and AI applications for healthcare data. PhD from MIT (2014) under John Guttag NSF CAREER Award recipient (2016) Humboldt Foundation Carl Friedrich von Siemens Award (2024) Her research addresses four key technical thrusts: Time-series analysis for predicting clinical outcomes Robust machine learning against spurious correlations Decision-making with causal inference and offline reinforcement learning Human-AI collaboration frameworks Notable methodological contributions include the FIDDLE preprocessing pipeline for clinical time-series data, foundational work on survival analysis, and novel approaches to model selection in healthcare reinforcement learning. Her work has led to real-world AI deployments in infection prevention and patient risk stratification. Scientific honors include: Forbes 30 Under 30 (2015) MIT Tech Review 35 Innovators Under 35 (2017) Sloan Research Fellowship in Computer Science (2020) Sarah Goddard Power Award (2023) Wiens collaborates with clinicians across disciplines, emphasizing clinician-in-the-loop AI systems and ethical implementation in healthcare workflows.
Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Mersema Abate, MD, MPH is an Associate Professor in the Department of Medicine and Science Education at the Zucker School of Medicine at Hofstra/Northwell. She also serves as Director of Advanced Clinical Experience at Northwell Health. Her research focuses on kidney transplantation outcomes, health disparities, and post-transplant glycemic control. She has published extensively on topics such as racial inequities in kidney transplant eligibility, electrolyte abnormalities in critically ill patients, and the impact of comorbidities on transplant success. Her work has been cited over 1,000 times, with notable contributions to understanding the role of race in clinical algorithms and managing infections in immunocompromised patients. Research Interests: Optimizing post-transplant metabolic control Addressing systemic disparities in organ transplantation Multimodal approaches to kidney failure management COVID-19's impact on renal and transplant medicine Publications: Her 70+ articles span peer-reviewed journals like Clinical Transplantation and Journal of the American Society of Nephrology , focusing on clinical nephrology and transplant medicine. Recent work emphasizes implementation of continuous glucose monitoring systems and re-evaluation of race-based clinical metrics. Grants/Advising: No formal grants or student advisees are currently listed in her profile.
Holly J. Benjamin, MD is a distinguished sports medicine specialist at the University of Chicago, serving as the inaugural Director of the Primary Care Sports Medicine Program at UChicago Medicine Student Wellness Center. She holds leadership positions including Chair of the Committee on Sports Medicine & Fitness for the Illinois Chapter of the American Academy of Pediatrics, and serves as Head Medical Team Physician for the WNBA Chicago Sky and medical officer for major events including the Bank of America Chicago Marathon, US Soccer, and USA Triathlon. Her educational background includes: B.S. in Integrated Life Sciences, Kent State University (1994) Combined BS/MD, Northeastern Ohio Universities College of Medicine (1994) MD, Northeastern Ohio Universities College of Medicine (1994) Residency in Pediatrics, The University of Chicago Children's Hospital (1997) Fellowship in Primary Care Sports Medicine, Lutheran General Hospital (1998) Dr. Benjamin specializes in sports medicine with particular expertise in youth, adolescent, and collegiate athletes. Her research spans acute and overuse sports injuries, concussion management, sport biomechanics, and musculoskeletal ultrasound. She has made significant contributions to understanding injury prevention strategies, safe return-to-play protocols, and the psychological aspects of sports injuries. Her work frequently addresses female athletes and elite/professional athletes, with emphasis on evidence-based approaches to optimize performance while minimizing injury risk. Recent publications demonstrate a strong focus on concussion research, with multiple studies examining diagnostic approaches, recovery trajectories, and factors influencing outcomes. Her work spans biomechanics, mental health considerations in sports injuries, and innovative approaches to injury prevention across various athletic populations. Her scientific recognition includes: Election as Fellow of the American College of Sports Medicine (2003), becoming the second female pediatrician ever elected Election as Fellow of the American Medical Society of Sports Medicine Distinguished Alumni Award from The New Aurora High School Alumni (1999) Invitation to serve as volunteer physician for the Olympic Training Center (2008) Multiple expert contributions to national media including Runner's World and the Naperville Sun Dr. Benjamin actively mentors through her coaching roles at high school and collegiate levels, emphasizing safe return-to-play post-injury and injury prevention. She has developed educational content through video productions for the American Academy of Pediatrics and serves as head team physician for the University of Chicago Lab School and the NCAA Division III UChicago Maroons. Notably, she is one of only a few sports medicine specialists in the country offering diagnostic and procedural musculoskeletal ultrasound in her office, demonstrating her commitment to advanced diagnostic capabilities for patient care.
Kevin M. Lynch is a Professor of Mechanical Engineering at Northwestern University's McCormick School of Engineering, where he also serves as Director of the Center for Robotics and Biosystems. His research spans multiple domains of robotics, with particular expertise in dynamics, motion planning, and feedback control of mechanical systems. Dr. Lynch received his Ph.D. in Robotics from Carnegie Mellon University in 1996, with a thesis on "Nonprehensile Robotic Manipulation: Controllability and Planning" under advisor Prof. Matthew T. Mason. He earned his B.S.E. with honors in Electrical Engineering from Princeton University in 1989. His research interests focus on robotics, particularly dynamics, motion planning, and feedback control of mechanical systems. He investigates mechanics, planning, and control of robotic manipulation (juggling, throwing, pushing, rolling, vibration, etc.) and locomotion. His work also explores self-organizing systems, particularly decentralized control of mobile sensor networks and swarm robotics, underactuated dynamic systems, and physical human-robot interaction with industrial applications. Recent research has expanded into bio-inspired active electrosense, underwater robotics, control and optimization for robot swarms, swarm shape control, and functional electric stimulation. Dr. Lynch's recent publications demonstrate a strong trend toward rehabilitation robotics and human-robot interaction, particularly in lower-limb exoskeletons for gait training and rehabilitation. His work bridges fundamental robotics research with practical applications in healthcare, showing increasing integration of swarm robotics principles with human-centered design. The publications also reveal continued strong contributions to fundamental robotics theory, particularly in swarm formation control and manipulation dynamics. George Saridis Leadership Award in Robotics and Automation (2022) Harashima Award for Innovative Technologies (2017) IEEE Fellow (2010) Charles Deering McCormick Professor of Teaching Excellence (2007-10) Society of Automotive Engineers Ralph R. Teetor Educational Award (2007) Early Career Award in Robotics and Automation (2001) McCormick School of Engineering and Applied Science Teacher Of The Year Award (1998-1999) NSF Career Award (1998) As Director of the Center for Robotics and Biosystems, Dr. Lynch oversees significant research grants and initiatives in robotics. He has made substantial contributions to robotics education through his "Modern Robotics" book and associated Coursera specialization, which has reached thousands of students worldwide. His professional service includes serving as Editor-in-Chief of IEEE Transactions on Robotics, where he oversaw a 90% increase in submissions during his tenure. Dr. Lynch leads research groups focusing on swarm robotics and rehabilitation robotics, with particular emphasis on the Center for Robotics and Biosystems at Northwestern University. His teams integrate expertise from mechanical engineering, electrical engineering, computer science, and rehabilitation medicine to develop innovative robotic systems for both industrial applications and healthcare solutions.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Owen R. White is a Professor in the Department of Epidemiology & Public Health at the University of Maryland School of Medicine, serving as Associate Director of the Institute for Genome Sciences and Associate Director of Research Collaboration & Development. He leads a team of 25 scientists and engineers developing genomic annotation pipelines and data analysis tools for state-of-the-art research in microbiome and multi-omic studies. His academic background includes: BS in Biotechnology from the University of Massachusetts (1985) PhD in Molecular Biology from New Mexico State University (1992) Postdoctoral Fellowship in Genome Informatics at the Institute for Genomic Research (TIGR) (1994) Dr. White's research spans bioinformatics, genomics, transcriptomics, and metagenomics with emphasis on data management, metadata standards, ontologies, and cloud systems. His work has been foundational for large-scale initiatives like the Human Microbiome Project (HMP) and Integrative Human Microbiome Project (iHMP), generating over 50,000 datasets totaling 10 terabytes of multi-omic data. Analysis of his recent publications reveals a strong trend toward neuroscience multi-omics (BRAIN Initiative), cloud-based data infrastructure, and ethical data sharing frameworks. His work consistently bridges microbiome research with emerging fields like single-cell analysis and Alzheimer's disease biomarker discovery through integrated data platforms. Notable awards include: Benjamin Franklin Award for Open Access in the Life Sciences (2015) Kumho Science International Award in Plant Molecular Biology and Biotechnology (2001) As Principal Investigator for major NIH-funded centers, he has secured sustained support for the HMP Data Analysis and Coordination Center and iHMP Data Coordination Center. His team's work combines fee-for-service models with collaborative research funding to maintain cutting-edge genomic analysis capabilities. The Institute for Genome Sciences houses his computational team responsible for developing production annotation pipelines, database systems, and visualization tools that serve researchers across the University of Maryland School of Medicine and national consortia.
Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .
Jessica Illuzzi is the Deputy Dean for Education and Harold W. Jockers Professor of Medical Education at the Yale School of Medicine, where she is also a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences. She plays a pivotal role in medical education leadership, curriculum development, and accreditation efforts, while maintaining an active research program in maternal and neonatal health. Harvard University, AB in Biochemical Sciences (1994) Harvard Medical School, MD (1998) Yale School of Graduate Studies, MS in Epidemiology (2006) Residency in Obstetrics and Gynecology, Yale-New Haven Hospital (2002) Her research focuses on the impact of obstetric interventions on maternal and neonatal outcomes, especially among low-risk women. Key areas include cesarean section, vaginal birth after cesarean (VBAC), group B streptococcus prophylaxis, and innovative maternity care models. She has led studies on labor management, health disparities, and quality improvement in obstetric care. Recent publications highlight trends in racial and ethnic disparities in maternal outcomes, validation of VBAC prediction tools, neonatal resuscitation guidelines, and integrated maternal-child care models in Haiti. Her work spans clinical epidemiology, health services research, and digital health interventions in obstetrics. Hellman Award (2017) Leah Lowenstein Award (2010) Roy M. Pitkin Award (2010) Bohmfalk Award (2007) Association of Professors of Gynecology and Obstetrics Teaching Award (2006) Dr. Illuzzi has been a strong advocate for medical education reform and student mentorship. She previously served as clerkship director and curriculum director, and has played key roles in Yale’s curriculum redesign and LCME reaccreditation. She has also led quality improvement initiatives in labor care and contributed to national guidelines on neonatal resuscitation. Her collaborative research network includes frequent co-authors such as Xiao Xu and Katherine Harper Campbell.
University of Illinois Urbana-ChampaignUnited States
Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.
